Skip to main content
Darrell H S Tan

Darrell H S Tan

Researcher

Aug 24, 2026

10:57
So where aren't we seeing uptake? What populations deserve sort of that equity focus at this point in time?
11:05
Um, so, so there's, there's many.
11:07
I mean, in the HIV epidemic, we know that, uh, we always wanna be thinking about some of the key populations that have borne a disproportionate burden.
11:15
And largely in Canada since the beginning of the epidemic, roughly half of the epidemic has occurred among gay, bisexual, other men who have sex with men.
11:24
However, within that group, there are actually many folks who are doing as a population or as a group actually fairly well in terms of PrEP uptake, and we see disproportionately low uptake among sexual minority men who may face intersecting identities that have been historically underrepresented.
11:45
So, for example, racialized GBM, gay, bisexual, other men who have sex with men, Black, Indigenous, two-spirit individuals are over-represented.
11:54
And then when we think about other populations aside from sexual minority men, as we mentioned a moment ago, Indigenous populations in some parts of the country, again, it's quite varied, right? There's many, many Indigenous identities and communities across this huge land, of course.
15:50
How can a physician walk through the risk assessment with a patient to determine if a strong recommendation should be made from our side of the table, as opposed to someone coming to us sort of self-identifying the risk?
5:29
Are you concerned that it's taking so long to arrive here?
5:32
Uh, you know, I've got faith in our regulatory s- apparatus here in Canada.
5:35
Their job is to carefully review the science, critically review every piece of documentation that they're provided by, uh, a drug company.
5:42
I think Canadians should be, um, pleased that we have a, a rigorous review process.
5:48
Um, does it take a little longer than we would like? Sure.
5:51
Maybe that happens to some extent, but I think it's a matter of, uh, Health Canada doing a s- a, a careful and thorough job at, at ensuring that a drug they are gonna say and ratify, you know, this, a, a, a, deserves regulatory approval because it's safe enough and effective enough for our populations.
6:06
I think that's a, a reasonable thing, uh, for them to do.

6 MINS LATER

11:50
Yeah.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.